Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
LOADING
|||
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -12.50% |
| Q2 2025 | -19.49% |
| Q1 2025 | -20.07% |
| Q4 2024 | -4.90% |
| Q3 2024 | -3.74% |
| Q2 2024 | -10.65% |
| Q1 2024 | -11.37% |
| Q4 2023 | -4.59% |
| Q3 2023 | -12.71% |
| Q2 2023 | -10.84% |
| Q1 2023 | -2.23% |
| Q4 2022 | -7.31% |
| Q3 2022 | 1.06% |
| Q2 2022 | -22.38% |
| Q1 2022 | -12.45% |
| Q4 2021 | -10.57% |
| Q3 2021 | -6.73% |
| Q2 2021 | -13.95% |
| Q1 2021 | -5.82% |
| Q4 2020 | -18.13% |
| Q3 2020 | -11.09% |
| Q2 2020 | 5.01% |
| Q1 2020 | -19.32% |
| Q4 2019 | -0.82% |
| Q3 2019 | -16.12% |
| Q2 2019 | -37.83% |
| Q1 2019 | -6.13% |
| Q4 2018 | -11.95% |
| Q3 2018 | -36.28% |
| Q2 2018 | -1.90% |
| Q1 2018 | -116.74% |
| Q4 2017 | -5.84% |
| Q3 2017 | -44.54% |
| Q2 2017 | 36.76% |
| Q1 2017 | 0.00% |